|
Boston Scientific faces reimbursement hurdles for lung-searing asthma …
FierceMedicalDevices (press release) (registration) Boston Scientific ($BSX) had high hopes for its electrode-tipped catheter treatment for asthma after snatching up the system in 2010 through its $193.5 million purchase of Asthmatx. But the company is hitting a wall with the product as insurers … |
View full post on asthma – Google News